|
At Merck, we believe nobody should go without access to the medicines and vaccines they need. Learn more about our Patient Assistance Programs at merckhelps.com.
Dr. Roger M. Perlmutter has been appointed executive vice president and president of Merck Research Laboratories, Merck's global R&D organization, effective April 15, 2013.
Dr. Perlmutter will succeed Peter S. Kim, Ph.D., who has served in the role since 2003. To ensure a seamless transition, Dr. Perlmutter and Dr. Kim will work closely together for an initial period, after which Dr. Kim will remain with the company as an advisor until his retirement in August.
BioEvery day, 800 women die unnecessarily during pregnancy and childbirth. Merck is dedicating itself to the vision that no woman should die to give life.
learn moreConserving and improving access to water is a global challenge.
learn more